Publications by authors named "Sara Vossoghian"

4 Publications

  • Page 1 of 1

Outcome of Kidney Transplantation From Living Donors With Multiple Renal Arteries Versus Single Renal Artery.

Iran J Kidney Dis 2016 Mar;10(2):85-90

Department of Nephrology, Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.

Introduction: Receiving a kidney transplant from donors with multiple renal arteries (MRAs) is suggested to be associated with higher risk of vascular and urologic complications and poor allograft outcomes compared to the donors with single renal artery (SRA). We evaluated survival rates in the recipients from donors with MRAs compared to those from donors with SRA.

Materials And Methods: In a retrospective study on 115 kidney allograft recipients, demographic characteristics and the outcomes of kidney transplantation were compared between the recipients from donors with MRAs compared to those from donors with SRA. These included acute tubular necrosis, acute allograft rejection, hypertension, vascular complications, urologic complications, kidney function indicators, and allograft survival at 1 year.

Results: There was no significant difference in the recipients' age, sex distribution, and weight, donors' age, donor-recipient familial relation, urologic complications, and duration of hospitalization between the two groups. However, MRA was significantly associated with a higher likelihood of right-side kidney donation, longer warm and cold ischemia times, and lower glomerular filtration rate and higher serum creatinine concentrations at discharge and 12 months after transplantation, as compared to SRA transplants. No significant difference was seen in late complications including hypertension and renal artery stenosis. One-year graft survival was slightly poorer in the MRA group than the SRA group.

Conclusions: Our results demonstrate that kidney allografts with MRAs are associated with risks but have acceptable outcomes during the 1st year after transplantation, as compared to SRA kidney allografts.
View Article and Find Full Text PDF

Download full-text PDF

Source
March 2016

Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation.

Arch Iran Med 2014 May;17(5):388-90

Resident of Internal Medicine, Uromia University of Medical Sciences, Iran.

Chronic Myelogenic Leukemia (CML) is a rare malignant disorder after solid organ transplantation, especially in renal transplant recipients. Imatinib Mesylate is currently approved as first line treatment of CML. Most reports on CML are from kidney recipients who received azathioprine  in combination with cyclosporine and prednisolone as immunosuppressive therapy. We report a case with CML who was treated with Mycophenolate Mofetil.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/0141705/AIM.0015DOI Listing
May 2014

Primary hyperparathyroidism in a case of chronic myelogenous leukemia.

Indian J Endocrinol Metab 2013 Sep;17(5):942-3

Department of Hematology/Medical Oncology, Urmia University of Medical Sciences, Urmia, Iran.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.4103/2230-8210.117201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784891PMC
September 2013

Gaucher disease in a 53-year-old Iranian man.

Indian J Endocrinol Metab 2013 Jul;17(4):767-8

Department of Hematology/Medical Oncology,Urmia University of Medical Sciences, Resident, Department of Internal Medicine, Urmia University of Medical Sciences, Urmia, Iran.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.4103/2230-8210.113782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743391PMC
July 2013